Denzel Eggermont

Denzel Eggermont

Auto-generated profile, based on publicly available information

Denzel Eggermont

VIB-UGent Center for Medical Biotechnology, Ghent, Belgium

Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 October 2021 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DMDeeksha Munnur
Deeksha Munnur
QTQiwen Teo
Qiwen Teo
DEDenzel Eggermont
Denzel Eggermont
HLHorace H. Y. Lee
Horace H. Y. Lee
FTFabien Thery
Fabien Thery
SSSumana Sanyal
Sumana Sanyal

1 October 2021 in Nature Communications
Verified
Journal Article
Open access
PDF file
FTFabien Thery
Fabien Thery
LMLia Martina
Lia Martina
CACaroline Asselman
Caroline Asselman
YZYifeng Zhang
Yifeng Zhang
MVMadeleine Vessely
Madeleine Vessely
FIFrancis Impens
Francis Impens
ISG15 is an interferon-stimulated, ubiquitin-like protein that can conjugate to substrate proteins (ISGylation) to counteract microbial infection, but the underlying mechanisms remain elusive. Here, we use a virus-like particle trapping technology to identify ISG15-binding proteins and discover Ring Finger Protein 213 (RNF213) as an ISG15 interactor and cellular sensor of ISGylated proteins. RNF213 is a poorly characterized, interferon-induced megaprotein that is frequently mutated in Moyamoya disease, a rare cerebrovascular disorder. We report that interferon induces ISGylation and oligomerization of RNF213 on lipid droplets, where it acts as a sensor for ISGylated proteins. We show that RNF213 has broad antimicrobial activity in vitro and in vivo, counteracting infection withListeria monocytogenes, herpes simplex virus 1, human respiratory syncytial virus and coxsackievirus B3, and we observe a striking co-localization of RNF213 with intracellular bacteria. Together, our findings provide molecular insights into the ISGylation pathway and reveal RNF213 as a key antimicrobial effector.

14 October 2022 in Nature Communications
Verified
Journal Article
Open access
PDF file
RMRupert Mayer
Rupert Mayer
RVRein Verbeke
Rein Verbeke
CACaroline Asselman
Caroline Asselman
IAIlke Aernout
Ilke Aernout
AGAdillah Gul
Adillah Gul
FIFrancis Impens
Francis Impens
Listeria monocytogenesis a foodborne intracellular bacterial pathogen leading to human listeriosis. Despite a high mortality rate and increasing antibiotic resistance no clinically approved vaccine againstListeriais available. AttenuatedListeriastrains offer protection and are tested as antitumor vaccine vectors, but would benefit from a better knowledge on immunodominant vector antigens. To identify novel antigens, we screen forListeriapeptides presented on the surface of infected human cell lines by mass spectrometry-based immunopeptidomics. In between more than 15,000 human self-peptides, we detect 68Listeriaimmunopeptides from 42 different bacterial proteins, including several known antigens. Peptides presented on different cell lines are often derived from the same bacterial surface proteins, classifying these antigens as potential vaccine candidates. Encoding these highly presented antigens in lipid nanoparticle mRNA vaccine formulations results in specific CD8+ T-cell responses and induces protection in vaccination challenge experiments in mice. Our results can serve as a starting point for the development of a clinical mRNA vaccine againstListeriaand aid to improve attenuatedListeriavaccines and vectors, demonstrating the power of immunopeptidomics for next-generation bacterial vaccine development.

14 August 2024 in Molecular & Cellular Proteomics
Verified
Journal Article
Open access
AGAdillah Gul
Adillah Gul
LPLecia L. Pewe
Lecia L. Pewe
PWPatrick Willems
Patrick Willems
RMRupert Mayer
Rupert Mayer
FTFabien Thery
Fabien Thery
FIFrancis Impens
Francis Impens
Listeria monocytogenes is a foodborne intracellular bacterial model pathogen. Protective immunity against Listeria depends on an effective CD8+ T cell response, but very few T cell epitopes are known in mice as a common animal infection model for listeriosis. To identify epitopes, we screened for Listeria immunopeptides presented in the spleen of infected mice by mass spectrometry-based immunopeptidomics. We mapped more than 6000 mouse self-peptides presented on MHC class I molecules, including 12 high confident Listeria peptides from 12 different bacterial proteins. Bacterial immunopeptides with confirmed fragmentation spectra were further tested for their potential to activate CD8+ T cells, revealing VTYNYINI from the putative cell wall surface anchor family protein LMON_0576 as a novel bona fide peptide epitope. The epitope showed high biological potency in a prime boost model and can be used as a research tool to probe CD8+ T cell responses in the mouse models of Listeria infection. Together, our results demonstrate the power of immunopeptidomics for bacterial antigen identification.

2 September 2026 in Communications Biology
Verified
Journal Article
Open access
PDF file
JGJoseph Patrick McGrail Gámiz
Joseph Patrick McGrail Gámiz
Irene Campaña GómezIrene Campaña Gómez
Irene Campaña Gómez
DEDenzel Eggermont
Denzel Eggermont
ATAntti Tuhkala
Antti Tuhkala
SKSalla Keskitalo
Salla Keskitalo
SGSusana Guerra
Susana Guerra
The sustained human-to-human transmission of Clade IIb monkeypox virus (MPXV) during the 2022 outbreak underscores the need to define host determinants of viral fitness across species. ISG15 encodes a ubiquitin-like modifier with antiviral activity, yet its role in MPXV infection and host adaptation remains unclear. Using representative strains from Clades Ib and II, we identify a striking species-specific difference in ISG15-mediated restriction. In murine cells, ISG15 deficiency primarily increases viral protein accumulation with minimal effects on infectious viral production, indicating limited antiviral restriction. In contrast, in human cells, ISG15 restricts replication of recent epidemic strains since ISG15 deficiency enhances viral growth, establishing ISG15 as a restriction factor in humans. ISGylome profiling identifies candidate viral and host substrates underlying this effect. Together, these findings reveal species-specific ISG15-dependent control of MPXV infection and support a model in which rodents serve as permissive reservoirs while humans represent a more restrictive host due at least in part to the antiviral activity of human ISG15.

17 November 2026 in Nature Communications
Verified
Journal Article
Open access
LPLaura Pedró-Cos
Laura Pedró-Cos
CMCorentin Mallet
Corentin Mallet
FTFabien Thery
Fabien Thery
PCPaul Courrieu
Paul Courrieu
JPJulien Pichon
Julien Pichon
CDCaroline Demangel
Caroline Demangel
Lipid droplets (LDs) accumulating in infected cells are traditionally viewed as passive nutrient stores exploited by invading pathogens. Here, we show that during infection with virulent Mycobacterium tuberculosis (Mtb), but not BCG, host LDs orchestrate protective immune responses by bridging the ISGylation and inflammasome pathways. Proteomic and imaging analyses reveal the selective recruitment of ISGylated proteins together with caspase-1 and interleukin-1β (IL-1β) precursors to the LD surface. Comparative LD proteomics in wild-type and ISG15-deficient macrophages, combined with ISGylome profiling, identify ISGylated proteins as mediators of pro-IL-1β binding to LDs. Functionally, disruption of LD biogenesis in primary human macrophages impairs mature IL-1β secretion and compromises Mtb control. Notably, this LD-dependent amplification of IL-1β release is not restricted to microbial stimuli but also occurs in response to sterile inflammasome activation. Collectively, these findings redefine LDs as immunoactive organelles integrating microbial and danger signals to potentiate inflammasome-dependent IL-1β responses during infection and inflammation.